期刊文献+

精准医学中个体化检验诊断的机遇与挑战 被引量:10

Opportunities and challenges of laboratory medicine based on personalized information in precision ;medicine
原文传递
导出
摘要 2015年美国政府提出“精准医学计划”后,精准医学的理念迅速播散,并推动现代医学从循证医学时代迈入精准医学时代,俨然成为未来医学的发展方向。伴随精准医学发展而产生的个体化检验诊断同样也是一个全新的领域,其复杂程度远远超乎人类当前认知。个体化检验诊断领域机遇与挑战同时并存,检验医学从业者应积极投身这一新兴领域,以期为寻找和评估循环生物标志物,选择适宜的分子诊断技术并使其标准化,高质量的生物标本的获得和样本库的建立,对报告单进行综合解读等领域作出贡献。最终实现对特定疾病和患者进行个性化精确治疗,改善疾病预防与诊治效果。 Since 2015, US government announced the Precision Medicine Initiative, the concept of“precision medicine” is spreading rapidly, which has seemingly become the mainstream of future medicine.Laboratory medicine based on personalized information brought by the development of precision medicine will be an entirely new area, however its complexity is far beyond the current knowledge and laboratory medical scientists are encouraged to be actively involved in this emerging field.Opportunities and challenges may coexist, which mainly include: screening and evaluation of circulating biomarkers, selection and standardization of appropriate molecular diagnostic techniques, acquisition of high quality biological specimens and establishment of sample library, and comprehensive interpretation of the results in order to achieve and improve individualized precise prevention, diagnosis, and treatment for specific diseases and patients.
作者 张钧 谢鑫友
出处 《中华检验医学杂志》 CAS CSCD 北大核心 2016年第9期657-660,共4页 Chinese Journal of Laboratory Medicine
基金 国家自然科学基金(81271914,81171629,81572042) 浙江省重大科技专项(2012C13019-2) 浙江省医学创新学科(11-CX18)
关键词 个体化医学 临床实验室技术 生物学标记 Individualized medicine Clinical laboratory techniques Biological markers
  • 相关文献

参考文献18

  • 1Collins FS, Varmus H. A New Initiative on Precision Medicine [J]. N Engl J Med, 2015,372(9):793-795.
  • 2Hood L, Friend SH. Predictive, personalized, preventive, participatory (P4) cancer medicine [J]. Nat Rev Clin Oncol,2011,8(3):184-187.
  • 3Jameson JL, Longo DL. Precision medicine-personalized, problematic, and promising[J]. N Engl J Med, 2015 , 372(23):2229-2234.
  • 4杨焕明.奥巴马版“精准医学”的“精准”解读[J].中国医药生物技术,2015,10(3):193-195. 被引量:30
  • 5Chen W, Zheng R, Baade PD,et al. Cancer statistics in China, 2015[J]. CA Cancer J Clin, 2016, 66(2):115-132.
  • 6Smith RA, Andrews K,Brooks D, et al. Cancer screening in the United States, 2016: A review of current American Cancer Society guidelines and current issues in cancer screening[J]. CA Cancer J Clin,2016,66(2):95-114.
  • 7Duffy MJ, O^onovan N, Crown J. Use of molecular markers for predicting therapy response in cancer patients [J]. Cancer Treat Rev, 2011, 37(2):151-159.
  • 8Pasic MD, Samaan S, Yousef GM. Genomic medicine: new frontiers and new challenges [J]. Clin Chem.2013,59(1):158-167.
  • 9Samuel N, Hudson TJ. Translating genomics to the clinic: implications of cancer heterogeneity [J]. Clin Chem, 2013 , 59(1):127-137.
  • 10Yu X, Schneiderhan-Marra N, Joos TO. Protein Microarrays for Personalized Medicine[J]. Clin Chem, 2010,56(3):376-387.

二级参考文献37

  • 1国家发展和改革委员会,卫生部,国家中医药管理局.关于规范医疗服务价格管理及有关问题的通知.201245^04.
  • 2Schuster SC. Next-generation sequencing transforms today's biology[J]. Nat Methods, 2008 , 5: 16 -18.
  • 3Mardis ER. The impact of next-generation sequencing technology on genetics[J]. Trends Genet, 2008,24: 133-141.
  • 4Soon WW, Hariharan M, Snyder MP. High-throughput sequencing for biology and medicine[J]. Mol Syst Biol, 2013 , 9: 640.
  • 5Miller MB,Tang YW. Basic concepts of microarrays and potential applications in clinical microbiology[J]. Clin Microbiol Rev,2009,22 : 6J1 -633.
  • 6Kimura H, Suminoe M, Kasahara K, et al. Evaluation of epidermal growth factor receptor mutation status in serum DNA as a predictor of responseto gefitinib[J]. Br J Cancer,2007 , 97 : 778-784.
  • 7Lianidou ES. Circulating tumor cell isolation: a marathon raceworth running[ J]. Clin Chem, 2014,60(2) :287-289.
  • 8Riethdorf S, Fritsche H, Muller V, et al. Detection of circulatingtumor cells in peripheral blood of patients with metastatic breastcancer: a validation study of the Cell Search system [ J ]. ClinCancer Res, 2007, 13(3) :920-928.
  • 9Gorges TM,Tinhofer I,Drosch M,et al. Circulating tumour cellsescape from EpCAM-based detection due to epithelial-to-mesenchymal transition[ J]. BMC Cancer, 2012(12) :178.
  • 10Gascoyne PR, Shim S. Isolation of circulating tumor cells bydielectrophoresis[ J]. Cancers ( Basel) , 2014, 6(1) :545-579.

共引文献42

同被引文献54

引证文献10

二级引证文献68

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部